Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1281-1290 of 1,467) with videos related to

Pageof 147
Sort By:
Pediatric Research|June 12, 2023
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profileAthena N Nguyen, Alec L Plotkin, Oludare A Odumade, et al.
Clinical Drug Investigation|July 12, 2025
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid ArthritisGerd Burmester, Jakub Trefler, Artur Racewicz, et al.
Annals of the Rheumatic Diseases|October 31, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, et al.
Rheumatology (Oxford, England)|March 22, 2021
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international studyLaura C Coates, Danielle E Robinson, Ana-Maria Orbai, et al.
Clinical and Experimental Rheumatology|October 13, 2022
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohortElisa Gremese, Francesco Ciccia, Carlo Selmi, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementMonika M Schoels, Désirée van der Heijde, Ferdinand C Breedveld, et al.
Joint Bone Spine|April 14, 2020
Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countriesPenélope Esther Palominos, Laura Coates, Charles Lubianca Kohem, et al.
Rheumatology (Oxford, England)|February 22, 2023
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world dataArno W R Van Kuijk, Mike T Nurmohamed, Stefan Siebert, et al.
Clinical and Experimental Rheumatology|September 3, 2016
The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016Kevin L Winthrop, Vibeke Strand, Désiréé M van der Heijde, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2017
The unmet need in rheumatology: Reports from the targeted therapies meeting 2017Kevin L Winthrop, Vibeke Strand, Désirée van der Heijde, et al.
Pageof 147

Showing results (1281-1290 of 1,467) with videos related to

Sort By:
Pageof 147
Pediatric Research|June 12, 2023
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profileAthena N Nguyen, Alec L Plotkin, Oludare A Odumade, et al.
Clinical Drug Investigation|July 12, 2025
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid ArthritisGerd Burmester, Jakub Trefler, Artur Racewicz, et al.
Annals of the Rheumatic Diseases|October 31, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, et al.
Rheumatology (Oxford, England)|March 22, 2021
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international studyLaura C Coates, Danielle E Robinson, Ana-Maria Orbai, et al.
Clinical and Experimental Rheumatology|October 13, 2022
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohortElisa Gremese, Francesco Ciccia, Carlo Selmi, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementMonika M Schoels, Désirée van der Heijde, Ferdinand C Breedveld, et al.
Joint Bone Spine|April 14, 2020
Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countriesPenélope Esther Palominos, Laura Coates, Charles Lubianca Kohem, et al.
Rheumatology (Oxford, England)|February 22, 2023
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world dataArno W R Van Kuijk, Mike T Nurmohamed, Stefan Siebert, et al.
Clinical and Experimental Rheumatology|September 3, 2016
The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016Kevin L Winthrop, Vibeke Strand, Désiréé M van der Heijde, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2017
The unmet need in rheumatology: Reports from the targeted therapies meeting 2017Kevin L Winthrop, Vibeke Strand, Désirée van der Heijde, et al.
Pageof 147